News Articles Tagged: Acne Vulgaris

Trifarotene: Mechanism of Action and Therapeutic Potential in Acne Vulgaris

Ningbo Inno Pharmchem Co., Ltd. explores Trifarotene's mechanism as a selective RARγ agonist and its therapeutic potential in treating acne vulgaris, highlighting its role as a key pharmaceutical intermediate.

Acne Vulgaris and Androgen Receptor Antagonists: A New Approach to Clearer Skin

Discover how androgen receptor antagonists, such as CB-03-01, offer a novel topical approach to managing acne vulgaris by targeting hormonal influences on skin.